Безопасность психотропных препаратов в период грудного вскармливания


А.В. Ушкалова, Е.А. Ушкалова

В обзоре обсуждаются вопросы безопасности психотропных препаратов (антидепрессантов, антипсихотиков, анксиолитиков и др.) при их применении в период грудного вскармливания. Показано, что применение многих психотропных препаратов совместимо с грудным вскармливанием. Женщины должны быть информированы о потенциальном риске и пользе их приема в период кормления грудью, а также обучены распознаванию ранних признаков токсического воздействия на детей. В случае развития у ребенка каких-либо неблагоприятных симптомов, которые могут быть связаны с приемом лекарственных средств матерью, грудное вскармливание следует немедленно прекратить.

Литература


1. Kramer MS. “Breast is best”: The evidence. Early Hum Dev 2010;86(11):729–32.


2. World Health Organization. Infant and Young Child Feeding. Geneva, Switzerland: World Health Organization, 2003. [Jan 26, 2009]. Available at http://www.who.int/en/


3. Burt VK, Suri R, Altshuler L, et al. The use of psychotropic medications during breast-feeding. Am J Psychiatry 2001;158:1001–09.


4. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics 2009;124(4):e547–56.


5. Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol No18: use of antidepressants in nursing mothers. Breastfeed Med 2008;3(1):44–52.


6. Hale, TW. Medications and Mothers’ Milk: A Manual of Lactational Pharmacology (12th ed.). Amarillo, TX: Hale Publishing, 2006.


7. Lusskin S, Misri S. Use of psychotropic medications in breastfeeding women. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2011.


8. Winans EA. Antidepressant use during lactation. J Hum Lactat 2001;17:256–61.


9. Hendrick V, Fukuchi A, Altshuler L, et al. Use of sertraline, paroxetine and fluvoxamine by nursing women. Br J Psychiatry 2001;179:163–66.


10. Armstrong C.ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation Practice Guidelines Am Fam Physician 2008;78(6):772–78.


11. Hendrick V, Altshuler L, Wertheimer A, Dunn WA. Venlafaxine and breast-feeding. Am J Psychiatry 2001;158:2089.


12. Schmidt K, Olesen OV, Jensen PN. Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol Psychiatry 2000;47:164.


13. Franssen EJF, Meijs V, Ettaher F, et al. Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit 2006;28:2–4.


14. Lee A, Woo J, Ito S. Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am J Obstet Gynecol 2004;190:218–21.


15. Lester BM, Cucca J, Andreozzi L, et al. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993;32(6):1253–55.


16. Hale TW, Shurm S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr 2001;40:681–84.


17. Chambers CD, Anderson PO, Thomas RG, et al. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999;104(5):e61.


18. Gentile S. Escitalopram late in pregnancy and while breastfeeding. Ann Pharmacother 2006;40:1696.


19. Merlob P, Stahl B, Sulkes J. Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel. Eur J Pediatr 2004;163:135–39.


20. Haas JS, Kaplan CP, Barenboim D, et al. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tob Control 2004;13(1):52–6.


21. Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 1985;2:1124.


22. Stiskal JA, Kulin N, Koren G, et al. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001;84:F134–35.


23. Misri S, Corral MMD, Wardrop AA, et al. Quetiapine augmentation in lactation. A series of case reports. J Clin Psychopharm 2006; 26:508–11.


24. Marshall AM, Nommsen-Rivers LA, Hernandez LL, et al. Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution. J Clin Endocrinol Metab 2010;95(2):837–46.


25. Hernandez LL, Collier JL, Vomachka AJ, et al. Suppression of lactation and acceleration of involution in the bovine mammary gland by a selective serotonin reuptake inhibitor. J Endocrinol 2011;209(1):45–54.


26.Lanza di Scalea T, Wisner KL Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 2009;52(3):483–97.


27. Frey OR, Scheidt P, von Brenndorff AI. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother 1999;33(6):690–93.


28. American College of Obstetricians and Gynecologists (ACOG). Use of psychiatric medications during pregnancy and lactation. Washington (DC): American College of Obstetricians and Gynecologists (ACOG);2008 Apr. 20 p. (ACOG practice bulletin; no. 92).


29. Lutz UC, Wiatr G, Orlikowsky T, et al. Olanzapine treatment during breast feeding: a case report. Ther Drug Monit 2008;30(3):399–401.


30. Galbally M, Snellen M, Walker S, Permezel M. Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Aust N Z J Psychiatry. 2010;44(2):99–108.


31.Whitworth A, Stuppaeck C, Yazdi K, et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol 2010;24(1):121–23.


32. Gentile S, de Tirreni C. Antipsychotic Therapy During Early and Late Pregnancy. System Rev Schizophr Bull 2010;36(3):518–44.


33. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776.


34. Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk [letter] Am J Psychiatry 1994;151:945.


35. Dev VJ, Krupp P. Adverse event profile and safety of clozapine. Rev Contemp Pharmacother 1995;6:197–208.


36. Mendhekar DN. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation [letter] J Neuropsychiatry Clin Neurosci 2007;19:196–97.


37. Yaeger D, Smith HG, Altshuler LL. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum. Am J Psychiatry 2006;163(12):2064–70.


38. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. Clin Psychiatry 2008;69(4):666–73.


39. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation. Part 1:Teratology. Obstet Gynecol 2009;113:166–88.


40. Kohen D. Psychotropic medication and breastfeeding. Adv Psychiatr Treat 2005;11:371–79.


41. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994;8:461–75.


42. Johnstone MJ. The effect of lorazepam on neonatal feeding behavior at term. Pharmatherapeutica 1982;3:259–62.


43. Clinical Management Guidelines for ObstetricianGynecologists Use of Psychiatric Medications During Pregnancy and Lactation. ACOG Practice Bulletin Focus 7:385–400, Summer 2009.


44. Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 2002;53(1):39–49.


45. Pons G, Francoual C, Guillet P, et al. Zolpidem excretion in breast milk. Eur J Clin Pharmacol 1989;37:245–48.


46. Darwish M, Martin PT, Cevallos WH, et al. Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. J Clin Pharmacol 1999;39:670–74


47. Yatham LN, Kennedy SH, O’Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(3):5–69.


48. NICE clinical guideline 38 Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care July 2006.


49. von Unruh G, Froescher W, Hoffmann F, Niesen M. Valproic acid in breast milk: how much is really there? Ther Drug Monit 1984;6:272–76.


50. Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997;130:1001.


51. Dreifuss FE, Santilli N, Langer DH, et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987;37:379–85.


52. Chaudron L. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 2000;61:79–90. 53. Merlob P, Mor M, Litwin A. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother 1992;26:1563–65.


54. Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr 1990;150:136–38.


55. Brent N, Wisner K. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998;37:41–4.


56. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy, pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000;41:709–13.


57. Johannessen SI, Helde G, Brodtkorb E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005;46:775.


58. Ohman I, Vitols S, Luef G, et al. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002;43:1157.


59. Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005;46:1621.


Похожие статьи


Бионика Медиа